In terms of extra-colon cancer risk, germline mutations in MSH6 and PMS2 have been associated with increased risks of both breast cancer and ovarian cancer, with a doubling of the likelihood of developing breast cancer by the age of 60 years [42]. Here, MSH6 is linked to breast carcinoma.